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Introduction: Fulminant cardiopulmonary failure is a severe complication of hand, foot and mouth diseases due to
enterovirus 71 infection, with a high mortality rate. The treatment is mainly supportive with aggressive
cardiopulmonary resuscitation. We report the use of continuous veno-venous hemofiltration in a patient with
pulmonary edema and shock due to enterovirus 71 infection. To the best of our knowledge, this is the first report
of the use of continuous veno-venous hemofiltration to successfully treat a patient with fulminant cardiopulmonary
failure due to enterovirus 71 infection.
Case presentation: A 36-month-old Asian girl presented to our hospital with pulmonary edema, refractory
hypotension and severe cardiac dysfunction due to enterovirus 71 infection. In addition to the standard
management and care, we performed continuous veno-venous hemofiltration to overcome refractory shock and
our patient eventually made a full recovery. At a three-month follow-up, a full assessment revealed no neurological
sequelae.
Conclusions: In the management of patients with enterovirus 71-related fulminant cardiopulmonary failure, early
continuous veno-venous hemofiltration may be considered as an alternative treatment to improve patient survival
and to prevent severe neurological disabilities.Introduction
Outbreaks of hand, foot and mouth disease (HFMD) have
occurred in Vietnam and other countries in the Western
Pacific region with high morbidity and mortality over the
last decades. In 2011, from the beginning of the year to
December, 106,508 cases and 162 deaths were reported in
Vietnam, with a high proportion associated with entero-
virus (EV71) [1]. Fulminant cardiopulmonary failure (CPF),
characterized by pulmonary edema, refractory shock and
severe left ventricular dysfunction, is the most severe com-
plication of EV71-associated HFMD. Most of the reported
patients with EV71-induced pulmonary edema have dete-
riorated and died within 24 hours of hospitalization [2].
The pathogenesis of severe EV71 infection remains unclear.
However, marked elevation of several cytokines and* Correspondence: huuphuc.phan@gmail.com
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reproduction in any medium, provided the orchemokines was noted in patients with brainstem encephal-
itis and pulmonary edema [3,4].
Current treatment for EV71-related CPF is mainly
supportive with aggressive cardiopulmonary resuscita-
tion. Several rescue therapeutic modalities, such as a left
ventricular assist device and extracorporeal life support
(ECLS), have been used for the treatment of EV71-
related CPF with limited results [5]. Recently, Jan et al.
reported a case series of 13 children with CPF due to
EV71 who had undergone either extracorporeal left ven-
tricular support or extracorporeal membrane oxygen-
ation. Although 10 out of 13 patients were successfully
weaned off ECLS, four out of five patients with hypotensive
CPF died, and one survived with severe neurological seque-
lae. In addition, a number of complications occurred
among patients on ECLS [5].
Over the last decades, with the application of continu-
ous renal replacement therapy (CRRT), outcomes of ser-
iously ill infants and children have improved. CRRT hasd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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multiple organ failure due to severe sepsis and septic
shock [6]. In addition, early and high-volume continuous
veno-venous hemofiltration (CVVH) improved the
hemodynamic status and cytokine removal in patients
with systemic inflammatory response syndrome and sep-
tic shock [7,8]. However, the effectiveness and clinical
experience in the use of this treatment modality in the
management of children with EV71-related cardiopul-
monary failure remains limited. Here, we report a child
with pulmonary edema, refractory shock and left ven-
tricular dysfunction due to EV71 infection who survived
after emergency treatment with CVVH therapy.
Case presentation
A previously healthy 36-month-old Asian girl was pre-
sented to us with two days of high fever and an ery-
thematous rash and vesicles on her hand and mouth.
The child did not have vomiting, diarrhea or cough. She
had several myoclonic jerks per day. On admission to
the department of infectious diseases at the National
Hospital of Pediatrics in Hanoi, Vietnam, our patient
had a temperature of 39°C per axilla. Her oxygen satur-
ation was 99% in room air. Her noninvasive blood pres-
sure (BP) was 116/77mmHg and her heart rate was 144
beats per minute. She appeared alert. An initial full
blood count revealed a white blood cell (WBC) count of
10,900 cells/μL. A chest X-ray was normal. HFMD stage
2b was diagnosed and she received paracetamol and
phenobarbitone for symptomatic treatment. Immuno-
globulin (1g/kg) was given intravenously for 8 hours.
About 30 hours after admission, the child rapidly dete-
riorated with respiratory distress, tachycardia and reduced
consciousness, and was admitted to the pediatric intensive
care unit (PICU). She immediately required endotracheal
intubation and positive pressure ventilation support. A
pinkish frothy secretion was noted in the endotracheal
tube. A physical examination at the time of PICU admis-
sion revealed a temperature of 40.0°C per rectum, a heart
rate of 210 beats per minute, an invasive arterial BP of 63/
30mmHg, and a mean arterial of BP 40mmHg. Her cen-
tral venous pressure was 6cmH2O. Pulse oximetry showed
80% saturation at a fraction of inspired oxygen (FiO2) of
1.0. Generalized crackles were noted bilaterally on auscul-
tation of her lungs. She had cool, mottled skin and a pro-
longed capillary refill time was noted. Her Glasgow coma
score was 6. An abdominal examination revealed no hep-
atomegaly. Her Pediatric Risk of Mortality III (PRISM-III)
score was 21.
The first chest radiograph taken on PICU admission
revealed bilateral pulmonary edema with normal heart
size (cardiothoracic ratio, 50%). Results of arterial blood
gas analysis were as follows: pH, 7.328; partial pressure
of oxygen (PO2), 99.7mmHg; partial pressure of carbondioxide (PCO2), 37.1mmHg; bicarbonate (HCO3
-),
19.4mmol/L; and oxygen saturation, 99% with FiO2 of 1.
Electrocardiography revealed a sinus tachycardia.
Two-dimensional and color Doppler echocardiography
demonstrated a mild dilated left ventricular with diffuse
hypokinesis. The ejection fraction (EF) and shortening
fraction (FS) of her left ventricle were 37% and 19%,
respectively.
Laboratory investigations revealed the following values:
WBC count 13,500 cells/μL, neutrophils 10,180 cells/μL;
lymphocytes 2,130 cells/μL; hemoglobin 12.6g/dL; platelet
count 188× 103 cells/μL; prothrombin time 12.7s; acti-
vated partial thromboplastin time 35.2s; fibrinogen 4.9g/L;
D-dimer 861ng/mL; blood urea nitrogen 3.7mmol/L; cre-
atinine 44μmol/L; blood glucose level 24mmol/L; sodium
125.4mmol/L; potassium 3.7mmol/L; chloride 95mmol/L;
calcium 2.02mmol/L; total bilirubin 0.5μmol/L; aspartate
aminotransferase 43.31IU/L; alanine aminotransferase
4.05IU/L; lactate dehydrogenase 435IU/L; creatine kinase
382.1IU/L; creatine kinase-MB 44IU/L; troponin T
0.297ng/mL; ammonium 58.7mg/L; lactate 2.94mmol/L;
C-reactive protein 0.39mg/L; total protein 68.3g/L; and al-
bumin 36.3g/L.
We confirmed that the child had pulmonary edema and
shock as complications of HFMD. The initial management
modalities were positive pressure mechanical ventilation
support, 10 mL/kg of normal saline given over 30 minutes,
and the administration of a dobutamine infusion. Our
patient’s arterial BP initially responded well to the dobuta-
mine and was stable for one hour, then her cardiovascular
status deteriorated quickly and her BP dropped to 45/
30mmHg. An epinephrine infusion was added with titrated
doses to stabilize our patient’s BP. Three hours after PICU
admission, although her mean arterial BP was stable at 65
to 75mmHg, our patient’s heart rate was consistently high
at 210 to 220 beats per minute, and the doses of dobuta-
mine, epinephrine and milrinone were 15μg/kg/min, 0.4μg/
kg/min and 0.5μg/kg/min, respectively.
After obtaining parental consent, CVVH was initiated
three hours after PICU admission. A double-lumen 8F
catheter (Gambro, Hechingen, Germany) was inserted
into the femoral vein using the Seldinger technique to
establish vascular access. We used the continuous hemo-
filtration Prisma machine (Gambro), and an M60 hemo-
filter with polyacrylonitrile (AN69) membranes. To
prevent clotting, unfractionated heparin was infused into
the blood circuit, with a titrated dose to achieve an acti-
vated clotting time of 140 to 160 seconds, or an acti-
vated partial thromboplastin time of twice the control.
We set the initial blood flow rate at 3mL/kg/min, then
increased it to an average of 5mL/kg/min. The substitu-
tion fluid (Hemosol BO; Gambro) was infused at a rate
of 60mL/kg/h in a pre-diluted manner. Fluid removal
from the machine was set at zero initially, and the rate
Phan et al. Journal of Medical Case Reports 2012, 6:159 Page 3 of 5
http://www.jmedicalcasereports.com/content/6/1/159then adjusted based on our patient’s fluids status and
central venous pressure. CVVH was sustained for 48
hours without any complication.
After starting CVVH, our patient’s hemodynamic status
became more stable (Figure 1). Her heart rate gradually
decreased, accompanied by a stable arterial BP. Two hours
after CVVH commenced, her heart rate was 175 beats per
minute, and the dose of epinephrine was tapered to 0.2μg/
kg/min. Six hours after starting CVVH, epinephrine was
discontinued. Dobutamine was tapered and discontinued
after 24 hours of CVVH. Milrinone was continued for 24
hours after CVVH was ceased, with a tapered dose to
0.25μg/kg/min. We discontinued CVVH after 48 hours
when our patient’s hemodynamic status was stable with a
heart rate of 150 beats per minute and BP of 100/
60mmHg. A cardiac ultrasound performed at 72 hours of
CVVH revealed an improved left ventricular kinesis, with
a left ventricular EF of 58% and FS of 29%. Her PRISM -
III score at 24 hours after CVVH was 7. Our patient was
successfully extubated 72 hours after CVVH was initiated.
A clinical examination revealed no neurological deficit
even though brain imaging investigations were not per-
formed. She was discharged home after 11 days of
hospitalization without any obvious sequelae. At a three-
month follow-up, a full neurological and development as-
sessment revealed no abnormality.
Echocardiography was performed and revealed a nor-
mal cardiac function with a left ventricular EF and FS of








Figure 1 Hemodynamic parameters prior to and after continuous ven
veno-venous hemofiltration; DBP: diastolic blood pressure; MAP: mean bloo
rate; PICU: pediatric intensive care unit.We measured some cytokines and chemokines in her
plasma and effluent fluid using enzyme-linked immuno-
sorbent assay techniques. The plasma level of interferon
gamma (IFN-γ), interleukin (IL)-8 and tumor necrosis
factor receptor 2 (TNF-R2) measured at the initiation of
CVVH were 112.4pg/mL, 141.0pg/mL and 3599.1pg/
mL, respectively; and at 24 hours after CVVH were
82.8pg/mL, 85.1pg/mL, and 2376.9pg/mL, respectively.
IFN-γ (40.8pg/mL) and IL-8 (7.4pg/mL) were also
detected in her ultrafiltration fluid at 24 h after CVVH
therapy.
Virological studies performed at the molecular labora-
tory failed to detect influenza virus, adenovirus, respira-
tory syncytial virus, Epstein-Barr virus and rhinovirus
from various specimens. However, EV71 ribonucleic acid
(RNA) was detected from a throat swab and tracheal
aspirates by reverse transcription polymerase chain reac-
tion techniques using EV71 specific primers [9]. Blood
cultures on hospital and PICU admission were negative.
Discussion
The outcome of children with EV71-induced fulminant
CPF is very poor. The majority of patients with pulmon-
ary edema die within 24 hours of hospitalization. In a
group of patients infected with EV71 with complications,
Chang et al. reported that all 11 patients with pulmon-
ary edema died and nine of them rapidly deteriorated
and died within 12 hours of PICU admission, while only
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children with EV71 infection-related cardiopulmonary
failure has been modestly improved. Jan et al. reported
favorable outcomes in six out of eight patients with stage
3a CPF (with hypertension) treated with extracorporeal
membrane oxygenation and/or extracorporeal left ven-
tricular support. However, four out of five patients with
stage 3b CPF (with hypotension) died and one survived
with a poor neurological outcome [5].
The mechanism of pulmonary edema and shock asso-
ciated with EV71 infection remains unclear. However,
studies demonstrated that pulmonary edema may result
from the increased pulmonary vascular permeability [10].
Systemic inflammatory response syndrome induced by a
mass release of cytokines, a ‘cytokine storm’, may be re-
sponsible for increased vascular permeability. Wang et al.
found that concentrations of plasma IL-10, IL-13 and
IFN-γ were all significantly higher in patients with pul-
monary edema than those without [3]. In addition, they
also found that several chemokines in plasma, including
IL-8, IFN-γ-induced protein-10, monocyte chemo-
attractant protein-1 and monokine induced by IFN-γ,
were significantly higher in patients with pulmonary
edema than in those with uncomplicated brainstem en-
cephalitis [4].
The other possible pathophysiological mechanism of
EV71-related fulminant CPF is massive release of cate-
cholamines, a ‘catecholamine storm’, as a result of brain-
stem encephalitis [10]. The impact of CRRT on the
catecholamine clearance in patients with severe EV71 in-
fection is unknown and requires further investigation.
However, Bellomo et al. found that, in patients with
hemodynamic instabilities requiring inotropic or vaso-
pressor support, continuous hemodiafiltration could re-
move catecholamines but did not significantly affect
plasma catecholamine levels and had no impact on
hemodynamic status [11]. Similar findings were found in
critically ill patients with acute renal failure: CRRT did
not produce significant catecholamine losses [12]. In our
patient, the epinephrine dose could be tapered after
starting CRRT therapy. Therefore, it was unlikely that
the hemodynamic improvement in our patient was the
benefit of catecholamine clearance.
The application of CRRT has improved the outcomes
of critically ill patients, especially those with multiple
organ failure due to severe sepsis and septic shock [6].
CRRT has been proposed to improve the outcomes of
patients with systemic inflammatory response syndrome
and sepsis. CVVH increases the removal of inflamma-
tory mediators or a pathogen’s toxin from the blood by a
convective mechanism and/or by adsorption to the mem-
brane of the hemofilter. The effectiveness of the therapy
depends on the time of initiation and the dose of ultrafil-
tration [13]. Early CVVH improved the hemodynamicstatus of adult patients with septic shock [7]. Peng et al.
reported a marked reduction of plasma levels of IFN-γ,
and IL-1, -2, -4, -10 and −13 in septic patients after CVVH
treatment. In addition, the clinical status of patients trea-
ted with CVVH improved significantly compared with
those without CVVH treatment [8].
To the best of our knowledge, this is the first case
reported in the medical literature about the application
of CVVH in management of EV71-related cardiopul-
monary failure. CVVH was chosen as the initial mode of
CRRT for our patient because the middle molecular
solutes such as cytokines are best cleared from the
plasma by the convective mechanism of CVVH [13]. In
addition, CVVH has been documented as an effective
mode of CRRT for sepsis and septic shock patients in
previous studies [7,8]. We started CVVH early when our
patient’s hemodynamic status was not stable, and used a
high-volume hemofiltration rate (60mL/kg/h). Our patient’s
hemodynamic status improved quickly after the initiation
of CVVH. The inotropes were tapered and discontinued,
and her cardiac function improved markedly after CVVH
therapy. The change in her plasma cytokines level and de-
tection of cytokines in the effluent fluid after 24 hours of
CVVH therapy indicated that cytokines were removed from
the blood.Conclusions
We conclude that CVVH may be an effective therapy in
the management of fulminant CPF due to EV71 infec-
tion. The beneficial effect of CVVH may depend on the
timing of the initiation of therapy and the dose of hemo-
filtration. Further studies are needed to confirm the
benefit of this therapy.Consent
Written informed consent was obtained from the patient’s
parents for publication of this case report and accompany-
ing images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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